Strategy for surveillance of adverse drug events.
Bright
Roselie A
RA
Surveillance and Data Analysis Branch in the Division of Compliance Risk Management and Surveillance, Office of Compliance, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, USA.
D016907:Adverse Drug Reaction Reporting Systems; D004345:Drug Industry; D016903:Drug Monitoring / Q000379:methods; D064420:Drug-Related Side Effects and Adverse Reactions; D006801:Humans; D004364:Pharmaceutical Preparations; D011358:Product Surveillance, Postmarketing; D011786:Quality Control; D012042:Registries; D014481:United States; D014486:United States Food and Drug Administration
D004364:Pharmaceutical Preparations